Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|---|
| 1 | ||||
| Confusional state | Confusional state | x | ||
| Feeling abnormal | Confusional state | x | ||
| Somnolence | Drowsiness | x | ||
| Eosinophilia | Eosinophilia | x | ||
| Headache | Headache | x | ||
| Leukopenia | Leukopenia | x | ||
| Nausea | Nausea | x | ||
| Nervousness | Nervousness | x | ||
| Tension | Nervousness | x | ||
| Tension | x | |||
| Skin disorder | Other dermatoses | x | ||
| Palpitations | Palpitations | x | ||
| Tachycardia | Tachycardia | x | ||
| Urticaria | Urticaria | x | ||
| Vertigo | Vertigo | x | ||
| Vomiting | Vomiting | x | ||
| Dry mouth | Dry mouth | x | ||
| Vision blurred | Vision blurred | x | ||
| Hyperpyrexia | Hyperpyrexia | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||
|---|---|---|---|---|
| Dysuria | x | |||
| Incontinence | x | |||
| Nocturia | x | |||
| Suprapubic pain | x | |||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |